Cargando…
Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months
Autores principales: | Yong, Mostyn RNO, Savi, Flavia M, Woodruff, Maria A, Saifzadeh, Siamak, Askin, Geoffrey N, Labrom, Robert D, Hutmacher, Dietmar W, Adam, Clayton J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340250/ http://dx.doi.org/10.1186/1748-7161-10-S1-O58 |
Ejemplares similares
-
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
por: Herford, A.S.
Publicado: (2017) -
Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Craniofacial Surgery
por: Ramly, Elie P., et al.
Publicado: (2019) -
Off-label use of rhBMP-2
por: Watts, Clark
Publicado: (2011) -
Alveolar cleft defect closure with iliac bone graft, rhBMP-2 and rhBMP-2 with zygoma shavings: Comparative study
por: Balaji, S. M.
Publicado: (2011) -
Quantification of rhBMP2 in bioactive bone materials
por: Lian, Huan, et al.
Publicado: (2020)